These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30803213)

  • 1. Study of Thymidylate Synthase (TS) and Dihydropyrimidine Dehydrogenase (DPD) Expressions on 5-Fluorouracil in Oral Squamous Cell Carcinoma.
    Akhter K; Enamur Rashid M
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):503-508. PubMed ID: 30803213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82.
    Kawasaki G; Yoshitomi I; Yanamoto S; Yamada S; Mizuno A; Umeda M
    Anticancer Res; 2011 Oct; 31(10):3521-6. PubMed ID: 21965773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma.
    Kobayashi H; Koike T; Nakatsuka A; Kurita H; Sagara J; Taniguchi S; Kurashina K
    Oral Oncol; 2005 Jan; 41(1):38-47. PubMed ID: 15598584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
    Kawasaki G; Yoshitomi I; Yanamoto S; Mizuno A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):717-23. PubMed ID: 12464897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in penile cancer].
    Zhao F; Tang J; Gou HF; Li LH; Dong H; Chen Y; Cheng K; Ding J; Chen X; Men HT; Liu JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):756-9. PubMed ID: 24325106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy.
    Tateishi Y; Tatemoto Y; Ohno S; Morishita K; Ueta E; Yamamoto T
    Cancer Lett; 2009 Feb; 274(2):187-93. PubMed ID: 18986760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of dihydropyrimidine-dehydrogenase and thymidylate-synthase in patients with pancreatic neuroendocrine neoplasms treated with 5-FU-based chemotherapy.
    Krug S; Boch M; Nimphius W; Gress TM; Michl P; Rinke A
    Pancreatology; 2017; 17(1):139-145. PubMed ID: 28027897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer.
    Hoque MO; Kawamata H; Nakashiro KI; Omotehara F; Shinagawa Y; Hino S; Begum NM; Uchida D; Yoshida H; Sato M; Fujimori T
    Int J Oncol; 2001 Nov; 19(5):953-8. PubMed ID: 11604993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil.
    Jensen SA; Vainer B; Sørensen JB
    Int J Cancer; 2007 Feb; 120(3):694-701. PubMed ID: 17096352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
    Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
    Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of sensitivity to 5-FU on the basis of thymidylate synthase (TS)/dihydropyrimidine dehydrogenase (DPD) activity and chromosomal analysis in micro tissue specimens of breast cancer.
    Ota D; Kusama M; Kaise H; Nakayama S; Misaka T; Tsuchida A; Aoki T
    Breast Cancer; 2004; 11(4):356-66. PubMed ID: 15604991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
    Harada K; Kawashima Y; Yoshida H; Sato M
    Oncol Rep; 2006 Jun; 15(6):1417-23. PubMed ID: 16685374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where should the specimen be excised for the chemosensitivity of colorectal cancer to 5-fluorouracil?
    Ushigome T; Kawahara H; Kobayashi T; Kobayashi S; Kashiwagi H; Yanaga K
    Hepatogastroenterology; 2010; 57(102-103):1090-4. PubMed ID: 21410037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma.
    Ide H; Kikuchi E; Hasegawa M; Kozakai N; Kosaka T; Miyajima A; Oya M
    BMC Cancer; 2012 Sep; 12():420. PubMed ID: 22998564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
    Huang CL; Yokomise H; Kobayashi S; Fukushima M; Hitomi S; Wada H
    Int J Oncol; 2000 Jul; 17(1):47-54. PubMed ID: 10853017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
    Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer.
    Shintani Y; Ohta M; Hirabayashi H; Tanaka H; Iuchi K; Nakagawa K; Maeda H; Kido T; Miyoshi S; Matsuda H
    Lung Cancer; 2004 Aug; 45(2):189-96. PubMed ID: 15246190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.